Big PHARMA / PhRMA hasta en la S.O.P.A....(III)

PhRMA senior VP Matthew Bennett had issued a statement in October expressing the trade group's support for the bill. "PhRMA applauds the introduction of the Stop Online Piracy Act and looks forward to working with Chairman Smith and members of the House Judiciary Committee on an issue critical to innovation in the U.S.," he wrote.

"America's pharmaceutical research and biotechnology companies invest billions of dollars each year researching and developing new medicines, and they depend on strong and reliable IP protections to continue their important work in research labs across the nation. Intellectual property rights afforded to America's pharmaceutical research companies help them recoup their incredible investments in the discovery of new medicines, and give them a chance to survive and fund further research in a highly competitive environment."

In testimony before the House Judiciary Committee, John Clark, Pfizer chief security officer, said passage of the bill is essential to protect U.S. consumers from knockoff "In trying economic times, it is important that sound policies support America's innovative industries - which employ millions of Americans - by protecting the intellectual property on which they depend." drugs that are potentially harmful. "For Pfizer, pharmaceutical counterfeiting is first and foremost an issue of patient health and safety," said Clark.

Ver anterior:

Big PHARMA / PhRMA hasta en la S.O.P.A....(II)